Symbiotec Pharmalab IPO subscribed 71x; GMP points to nearly 27% listing gains

Symbiotec Pharmalab IPO drew strong demand on the final day, with the issue subscribed 71.26 times. QIBs led the bidding at 172.03 times, while the retail portion was subscribed nearly 13 times.
Key takeaways
- Category: Stocks.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.












